ICON plc - Clinical Research Organisation (CRO) for Drug Development

Live Active Patient EHR Data

ICON and Practice Fusion extend partnership to provide live Active Patient EHR data for clinical records.

Disruptive Innovation – The Impact

Read the views of 3 Senior Pharma Executives on how their organisations are approaching innovation.

FIRECREST

Site performance ignited: Digital solutions increase efficiency in clinical trials by driving site performance.

ICON Insights

24 September 2018

Simplifying the process of documenting Analysis Results Metadata (ARM)

Automating the process for Define –XML with ARM

18 September 2018

Smart Bioanalytical Strategies in Immuno-Oncology Trials

Discover the latest biomarker-based methods and how they can be leveraged to add value to oncology trials.

29 August 2018

CDISC Legacy Data Conversion

ICON’s Data Management team provides advice and guidance on legacy conversion process and what you need to implement to remain compliant.

27 August 2018

Precision Medicine Opportunities for Device Developers

Medical device developers are emerging into the precision medicine market in a variety of therapeutic areas, including neurology, cardiology and infectious diseases.

01 August 2018

Five Key Considerations for Writing First-in-Human Protocols Under EMA Guidelines

As pharmaceuticals move from animal to first-in-human (FIH) clinical trials, establishing appropriate strategies to minimise risk in early phase clinical trials is necessary.

04 July 2018

What Motivates Patients to Participate in Multiple Clinical Trials?

Successful clinical trial recruitment requires a thorough understanding of the target patient profile, and a key factor within this profile is patient motivation.

25 June 2018

FDA Acceptance of Clinical Data Collected Outside the U.S.

The US Food & Drug Administration (FDA) amended requirements for the acceptance of clinical data cllected outside the US to support medical device submissions.

21 June 2018

Harnessing Blockchain Technology and Digital Disruption

The opportunity for blockchain in healthcare and clinical trials.

15 June 2018

The Future of Automation and Digital Transformation in Late Phase Research

Late phase studies are ripe for digitalisation, although not always in the same ways as Phase II and III programs.

Services

Therapeutics

Innovation

Insights

News & Events

About ICON

Key Considerations for Parkinson’s Disease Trials

Immuno-Oncology

Improving Pharma R&D Efficiency

Value Based Healthcare